Ontogeny of angiotensin II type 2 (AT2) receptor mRNA in the rat. To study the distribution of the recently cloned angiotensin II type 2 (AT2) receptor in the rat fetus, a double stranded eDNA was generated by a new and recently described methodology requiring no cloning procedure. The eDNA obtained after reverse transcription (RT) and polymerasc chain reaction (PCR) amplification corresponded to 500 base pairs of the gene coding sequence, and included the SP6 and T7 promoters at the 5' and 3' end, respectively. 35S-labeled cRNA sense and antisenae probes were synthesized by in vitro transcription and used for in situ hybridization. From 13 to 19 days of gestation the AT2 receptor mRNA expression evolved and extended from a series of paired spots located para-axially, which were not identifiable at this level of observation, to a distribution in various mescnchymcs (perichondrium, subepidermal layers), muscle cells (tongue, diaphragm, stomach), and classical target organs for Aug II (adrenal gland, kidney, aorta). During the first days after birth, the AT2 receptor mRNA decreased and remained detectable only in the adrenal gland and kidney. The distribution of the AT2 receptor mRNA appeared strikingly different from that of the AT1A receptor, which was studied in parallel for comparison.
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Angiotensin II (Ang II) is most commonly known as a hormonal factor regulating water and salt homeostasis and vasoconstriction with the kidney, adrenal gland and vascular smooth muscles as primary targets, and hence participates in the control of blood pressure. However, a growing body of evidence shows a role of this peptide as a growth factor in vitro and possibly in vivo [1, 2] . Whatever the role of Ang II, the current consensus is that it acts via plasma membrane receptors coupled to intracellular signaling systems. This mechanism ensures that a single message can produce various effects in different target cells according to their intrinsic properties and content of Ang II receptor types.
Ang II binds to at least two pharmacologically distinct types of receptors, type 1 (AT1) and type 2 (AT2). Both these receptors have similar affinities for Ang II, but they have strikingly different properties towards peptidic and non-peptidic antagonists : AT1 has a high affinity for losartan (DuP 753), AT2 for PD123177 and CGP 42112 [1, 2] .
Functionally, the AT1 receptor appears to mediate most or all of the known effects of Ang II. The cloning of the AT1 receptor cDNA has revealed the existence of two closely related isoforms Received for publication June 17, 1994 and in revised form September 12, 1994 Accepted for publication November 3, 1994 © 1995 by the International Society of Nephrology (AT1A and ATIB), at least in murine species [3] [4] [5] [6] [7] . Important differences were observed at the level of their tissue distribution and regulation [8] [9] [10] [11] . Although the function of the AT2 receptor type remains unknown, binding studies have shown a well defined distribution of the AT2 receptor type in the adult rat uterus, ovary, adrenal gland, kidney, brain [1, 2] , as well as in the rat fetus at the end of gestation [12] [13] [14] .
The recent cloning of the AT2 receptor eDNA in rat [15, 16] or in mouse [17] showed that, like the AT1 receptor, it belongs to the family of the seven transmembrane domain receptors. These two receptor types are 34% identical in their amino acid sequence. The signal transduction mechanism(s) of the AT2 receptor is debated [1, 2, 15] as well as its functions, even though its expression during fetal development and its disappearance after birth suggest a role in organogenesis.
As Ang II antagonists will be used clinically to control blood pressure, it is crucial to identity the tissues that express the Ang II receptor genes and determine whether or not they are involved in cardiovascular homeostasis. Expression of a functional receptor at the cell surface can be affected at the level of transcription of the mRNA, stability of the message, translation into protein, transport to the cell surface and enzymatic modifications affecting activity or binding. Hence it is of particular interest to characterize the spatiotemporal pattern of expression of the AT2 receptor mRNA to study the expression of this receptor gene. The present in situ hybridization study of AT2 receptor mRNA expression during development could be useful to validate and complete already existing data obtained by in situ autoradiographic binding studies.
Using the published sequence of the AT2 receptor eDNA [15, 16] a polymerase chain reaction (PCR) product corresponding to the first 160 amino acid sequence of the rat AT2 receptor was synthesized by reverse transcriptase (RT) PCR amplification of rat adrenal total RNA. This new method [18] involves a reverse transcription and PCR amplification, using primers containing specific sequences of the AT2 receptor and additional sequences of the T7 and 5P6 RNA polymerase promoters. Sense and antisense cRNA probes were generated in vitro from this amplicon and used for in situ hybridization to establish the spatiotemporal expression of the AT2 receptor mRNA in the fetal and newborn rat, with particular emphasis on the kidney and adrenal gland. This distribution was compared to that of AT1A receptor mRNA.
Method
Primer design DNA sequences were chosen to amplify a 500 bp fragment. The primers, selected in the rat AT2 eDNA sequence [15, 16] , displayed no homology with the rat AT1Aor ATIB cDNA sequences [3, 4] . Sequences for T7 or SP6 promoters along with additional sequences required for optimal transcription efficiency for each polymerase [19] were added respectively to the sense and antisense primers. The primers were synthesized using a PCR-mate 391 device (Applied Biosystems). The sense primer contained the T7 promoter sequence and 23 bp of the AT2 receptor sequence (5'-TAA TAC GAC TCA CTA TAG GGG ATC ATG AAG GAC AAC TIC AGT TTr GC-3'). The reverse primer contained the SP6 promoter sequence and 22 bp of the AT2 receptor buffer (pH 8.3), 65 mvi KCI, 2.5 mivi MgCl2, 0.5 miu dNTP, 2 mM dithiothreitol and 0.01% gelatin for 35 cycles at 92, 54 and 72°C for 1.00, 1.00 and 1.30 minutes, respectively. PCR products were electrophoresed in 1.5% agarose gels and visualized by ethidium bromide staining. Restriction enzyme analysis of PCR products was performed on 20 d of the PCR reaction medium, which was diluted twofold in autoclaved H20 and incubated for 90 minutes at 37°C in presence of KpnI (10 units) or Apal (10 units).
Digestion analysis was resolved by separating the different fragments on 1.5% agarose gel for visual verification.
Sequencing of PCR products PCR products were gel purified using the Qiaex gel extraction kit (Qiagen, Invitrogen, Oxon, UK) and submitted after denaturation to direct sequencing on both strands by the dideoxynucleotide chain termination method using a Sequenase kit (United States Biochemical Corp., Cleveland, OH, USA). The denaturation step of the template DNA was performed by heating for five minutes at 94°C in the presence of 10 pmol of sequencing primer and DMSO, then by chilling in ethanol/dry ice. Sequencing reactions were stopped by the addition of formamide, run on a 6% denaturing polyacrylamide gel and visualized by autoradiography.
Labeling of complementary RNA (cRNA) probes cRNAs were transcribed by RNA polymerases (Promega Biotech, Madison, Wis, USA) in the presence of 35S-UTP (Amersham, Les Ulis, France), starting from the SP6 or T7 promoter sequence, using 7 pA of the PCR reaction product. The labeled transcription products were verified on a 1.2% agarose gel. The ATIA eDNA was prepared following a previously described procedure [10] , linearized by Asel and transcribed by T3 RNA polymerase to synthesize the ATIA antisense cRNA probe, and likewise the AT1A sense probe was produced after linearization by BamHI and transcription by T7 RNA polymerase.
In situ hybridization
Timed pregnant rats (Sprague Dawley, purchased from IffaCredo, Les Oncins, France) were sacrificed by lethal chloroform anesthesia at 13 (E13), 15 (E15), 17 (E17) and 19 (E19) days of gestation, and the fetus, either together with the placenta (E13) or alone, were removed from the mother and fixed by immersion in 4% paraformaldehyde. Newborn rats at day 0 (DO; 2 hr postpartum), 1 (DI), 3 (D3), and 10 (D1O) were sacrificed by decapitation under chloroform anesthesia and the organs taken out to be fixed. The hybridization procedure (tissue preparation, paraffin embedding, prehybridization, hybridization and posthybridization washes) was as previously described [10, 20] . The hybridization signal was observed macroscopically after autoradiography of the sections on J3-Max (Amersham) or X-OMAT AR (Kodak, Rochester, NY, USA) films for 3 to 5 days. The slides were dipped in liquid emulsion (NTB2, International Biotechnologies, mc, New Haven, CT, USA), and after two weeks of exposure, they were photographically processed and counterstained with toluidine blue.
Results
To prepare a specific rat AT2 riboprobe, total RNA from rat adrenals and an antisense primer including both the sequences of the AT2 receptor and the SP6 RNA polymerase promoter were used as templates. Single cDNA strands were obtained by reverse transcription. Double cDNA strands were synthesized by PCR amplification between this reverse primer and a sense primer including both the sequences of the AT2 receptor and the T7 RNA polymerase promoter (Fig. 1) . These conditions produced only one PCR product with the expected size of 544 bp (499 bp of the AT2 receptor and 45 bp of the SP6 or T7 promoter sequences). The digestion of this product by KpnI or Apal generates fragments of either 453 and 94 bp or 299 and 248 bp, respectively (Fig. 2) , in agreement with the restriction map of the AT2 receptor cDNA [15, 16] . Furthermore, the sequence analysis of the PCR product by directly sequencing both strands without subcloning allowed the identification of 200 out of 499 bp, corresponding to the nucleotides 65 to 165 and 305 to 405 of the rat AT2 receptor sequence [15] . Taken together, these results demonstrated that the synthesized PCR product corresponds to the 1 to 499 bp of the rat AT2 receptor cDNA.
Direct transcription of this PCR product without purification (considering that all the RT-PCR amplification procedure was performed in RNase free solutions) produced 35S labeled sense and antisense RNA probes (specific activity 1.5 x 108 cpm/jg) by the use of respective T7 and SP6 RNA polymerase promoters. Analysis of the transcription products by agarose gel electrophoresis, followed by autoradiography, showed the presence of a single band of the expected size (547 bp) for the sense as well as for the antisense riboprobes, demonstrating in each case the synthesis of full length cRNA transcripts (Fig. 3) . These cRNA probes were subsequently used for mapping the AT2 receptor mRNA by in situ hybridization.
Tissues were hybridized with the AT1A and AT2 sense and Total RNA from rat adrenals was used as a template to synthesize a single strand eDNA in the presence of a specific reverse primer including the sequence of the SP6 promoter and that of the AT2 receptor. Double stranded eDNAs were obtained after PCR amplification between this reverse primer and a sense primer including the sequence of the T7 promoter and that of the Al'2 receptor. The PCR product was then directly used for synthesizing cRNA probes in a transcription reaction with either T7 or SPb RNA polymerase in the presence of 35S-UTP.
antisense probes. The overall distribution of ATIA and AT2
receptor mRNAs shown by in situ hybridization in the rat fetus is different for each receptor type (Fig. 4) . AT1 A mRNA was detected at all stages studied, either as a weak and diffuse labeling at E13, or as a distinct signal located in definite organs or parts of organs at later stages (E15 to E19): kidney, adrenal cortex, liver, lung, heart, aorta, pituitary gland and brain. A diffuse but strong labeling was also observed in the para-axial mesenehyme of the back at E15, of the tail at EU, and in the epidermis at E19. Absence of labeling was seen at E17 with the ATIA sense probe. In contrast, AT2 receptor mRNA was first detected at E13 as a series of small paired spots symmetrically located on each side along the embryo axis (not shown). As early as E15 the differentiating kidney displayed a hybridization signal in the cortex and/or the capsule (Fig 4) . In the adjacent adrenal gland the outer layer of the cortex was strongly labeled. At E15, a signal was observed in the para-axial mesenehyme in the lower part of the body, and a very intense signal in the tongue and the pharyngeal region. In the fetus at E17, the distribution and intensity of labeling did not change significantly as compared to E15. The labeling of the tongue remained very strong and expanded as the tongue grew. In addition, the skin was distinctly positive at some regions of the back. At 19 days of gestation, all organs above described as labeled, remained positive for the AT2 probe. The strong signal in the adrenal gland appeared to be restricted to the capsule and the zona glomerulosa of the adrenal cortex, and in the medulla, whereas the adjacent kidney displayed a weaker labeling, in outer medulla and cortex. In the deeper layers of the skin, the labeling was generalized over the whole body. The tissue surrounding the -463 vertebrae and ribs showed a clear signal, as did the outline of the stomach, the trachea, the bronchi and the aorta. In the head, the -299 tongue, the whole phatyngeal area, and particularly the epiglottis, displayed the strongest signal together with the snout and nasal -248 cavity. The skin and the inner lining of the bueeal cavity were also labeled. As a control, no significant signal was observed at any developmental stage with the AT2 sense probe. For technical reasons, it was impossible to work with the whole body of newborn rats, even one hour after birth. The size of the newborn and the low permeability of keratinized skin to the various solutions (fixatives and dehydration solvents) precluded the use of whole body sections. Organs were therefore dissected and individually processed.
After birth (Figs. 5 and 6 ), ATIA receptor mRNA was detected in the kidney, heart, thymus, adrenal gland (zona glomerulosa and medulla), pituitary gland and liver. AT2 receptor mRNA remained detectable in the adrenal gland after birth and until adult life. In the newborn at D3 and in the adult adrenal gland, microscopic images revealed the presence of AT2 mRNA only in the zona glomerulosa, and no labeling was seen in the zona faseieulata and zona retieularis (Fig. 6 A, C) . In the medulla the : frontal sections of the head of a newborn rat at DO; bi and b2: skin of newborn rat at DO; ci and c2: heart and thymus at Di; dl and d2: kidney and adrenal gland at D3; ci and e2: kidney at DlO. To: tongue; Th: thymus; Br: bronchus; Md: adrenal medulla. Magnification X2.
labeling was heterogeneous as if only some cords of cells were positive. In the kidney, the labeling was clearly visible although weaker than in the adrenal gland, and it appeared to be located mainly in the outer cortex and medulla. The signal in the kidney decreased between D3 and D1O (Fig. 5) . The heart displayed a weak labeling comparable to the background obtained with the sense probe. In the head, at DO and Dl the same structures as in the 19-day-old fetus remained positive: tongue, walls of the buccal cavity and lateral jaw muscles. In addition, the lining of the orbital cavity and a subepidermal layer of the skull were also labeled. The tongue remained labeled at Dl but was not examined at later stages. The labeling in the skin at DO and Dl was much weaker than in the fetus.
Discussion
The simple method initially described by Bean, Simons and HOkfelt [18] was utilized, after slight modification, to generate AT2 receptor single stranded cRNA probes that were used to establish the distribution of the AT2 receptor mRNA in the rat fetus and the newborn rat. The AT2 receptor mRNA was detected in known target organs for Ang II (kidney, adrenal gland, large blood vessels) and also in various tissues where no hormonal effect of this peptide has been described, particularly in differentiated and undifferentiated mesenchymes. AT2 receptor mRNA was detectable at the earliest stage studied, 13 days of gestation. The AT1A receptor mRNA was also detected in targets organs for Ang 11, some of which are the same as for AT2 (kidney, adrenal gland, large blood vessels) and others which are unique to ATIA (liver, lung, pituitary gland). Similarly, some of the mesenchymes which express AT1A receptor mRNA also express AT2 (perichondrion), but others express only AT2 (tongue, bronchi). The distribution of AT1 A and AT2 receptor mRNAs appears to be specific for each of the receptor types, an observation which favors a selective role for AT1 and AT2 receptors.
The distribution of the AT1 and AT2 receptor mRNAs in the fetus and the newborn generally coincides with the distribution of Ang II binding sites as shown by in situ autoradiography [12] and more specifically with AT2 binding studies using selective ligands [13, 14] . These in situ autoradiographic studies have revealed the presence of AT2 receptors in the rat fetus, in the same tissues and organs that are shown in the present study to express AT2 receptor mRNA, with the notable exception of the fetal and newborn zona glomerulosa. Indeed, both in situ binding studies which selectively detected AT2 receptor [13, 14] did not mention the presence of binding sites in this tissue, which is one of those displaying the strongest hybridization signal for AT2. The discordance between the in situ hybridization and in situ autoradiographic binding studies could be related to differences in the turnover rate of the mRNA and the protein.
Another interesting observation is the differential expression of the AT2 receptor during development between the kidney and the adrenal gland. While a high level of AT2 receptor mRNA expression persists in the adrenal (zona glomerulosa and medulla), the labeling tends to decrease between D3 and D10 in the kidney. There are conflicting results concerning the presence of AT2 binding sites, detected by autoradiography, in the kidneys. While Ciuffo et al [21] reported AT2 binding sites in immature glomeruli of fetal and newborn rat kidney, Grady et al [13] and Tsutsumi et al [14] did not mention AT2 binding sites in the kidney in their study using the rat fetus. Other studies in the adult rat failed to detect significant levels of AT2 receptor binding in the kidney [22, 23] . The present study shows that the AT2 receptor is expressed in the kidney, until at least 10 days after birth with an apparently different distribution from that of AT1, as revealed by in situ hybridization [24] [25] [26] . The identification of the cells in which AT2 receptor mRNA is expressed will help to understand the potential roles of Ang II via this receptor type in the kidney.
It is generally agreed that the AT2 receptor is mainly present during fetal life and disappears at birth [13, 141 . Thus, this receptor type could be involved in an Ang II induced differentiation process during development. The present study supports this view by showing the spatiotemporal regulation of the AT2 receptor mRNA expression in the rat fetus, particularly in various mesenchymes. It should be noted, however, that the ATIA receptor is also expressed during fetal life, with a different and wider pattern of distribution, and could therefore also play a role during development. Even though the AT2 receptor may not mediate the known physiological functions of Ang II in the kidney or the adrenal gland, since no definitive effect can be ascribed to the binding of Ang II to this receptor type, the AT2 receptor may be involved in the organogenesis of these organs as well as in the differentiation process of various mesenchymes in which the AT2 receptor mRNA is detected. Microscopical and physiological studies will be necessary to identify and characterize the target cells for Ang II and to clarify the exact role(s) of AT2 as well as AT1A receptors in the development.
